Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119251163 | 11925116 | 3 | F | 20160825 | 20160118 | 20160831 | EXP | PHHY2016PA005111 | NOVARTIS | 96.00 | YR | F | Y | 0.00000 | 20160831 | CN | PA | PA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119251163 | 11925116 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | PATCH 5 CM2, QD | 22083 | 4.6 | MG | TRANS-THERAPEUTIC-SYSTEM | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119251163 | 11925116 | 1 | Amnesia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119251163 | 11925116 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119251163 | 11925116 | Application site erythema | |
| 119251163 | 11925116 | Application site hypersensitivity | |
| 119251163 | 11925116 | Fall | |
| 119251163 | 11925116 | Musculoskeletal pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119251163 | 11925116 | 1 | 201509 | 201602 | 0 |